Ewing Sarcoma Breakpoint Region 1 (EWSR1) Peptide
EWSR1
Reactivité: Humain
Hôte: Synthetic
BP, BI
N° du produit ABIN5685042
Aperçu rapide pour Ewing Sarcoma Breakpoint Region 1 (EWSR1) Peptide (ABIN5685042)
Antigène
EWSR1
(Ewing Sarcoma Breakpoint Region 1 (EWSR1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), BioImaging (BI)
-
-
Attributs du produit
- EWS peptide corresponds to 16 amino acids of EWS.
-
-
-
-
Indications d'application
- EWS Peptide is used for blocking the activity of EWS antibody . The EWS antibody ships at 0.5 mg/mL and the EWS Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- EWS peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
-
Vous êtes ici:
